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This dissertation presents results of a medical image analysis project
leading towards development of a comprehensive set of methods and tools
for computational image analysis of dynamic contrast-enhanced (DCE) breast
magnetic resonance image (MRI), with the aim to aid the physician in inter-
preting DCE breast MRI examinations. Toward this goal, we developed im-
age analysis methods that would be needed in a breast MRI computer aided
diagnosis (CADx) system. A novel contribution of this dissertation is the per-
formance evaluation for each of the major algorithm components developed in
this dissertation project.
This dissertation begins with reviewing breast imaging techniques, including
routinely used modalities in current clinical practice and emerging techniques
still in development. We discuss at length the principles of DCE breast MRI,
vii
a very sensitive breast imaging modality that has been increasingly used in
clinical practice. Then we review the diagnostic guidelines for interpreting
DCE breast MRI, and explain the needs and challenges that arise in develop-
ing computational image analysis system for breast MRI applications.
In this dissertation project, both the morphological and kinetic features of the
lesion are automatically extracted for diagnostic purpose. In order to extract
morphological features from the segmented lesions, the lesion needs to be accu-
rately segmented out from its surrounding tissues. We utilized a probabilistic
method to obtain an optimal segmentation map based on several algorithmic
segmentation outputs. In evaluating the performance of segmentation algo-
rithms, we compared the algorithmic segmentation results against manually
segmented lesions, and further assessed the segmentation impact on subsequent
classification stage. In order to extract accurate kinetic information, the mo-
tion needs to be compensated across image volumes acquired sequentially. In
this dissertation, we comparatively assessed the similarity metric in registering
DCE breast MR images. The performance of cross correlation(CC) coefficient,
and mutual information (MI) were studied in both rigid and non-rigid regis-
tration schemes. Numerical results and statistical properties were reported.
The resultant image quality after registration is discussed both qualitatively
and quantitatively. In this dissertation we implemented a classification sys-
tem based upon quantitative morphological and kinetic features in improving
the specificity of breast MRI. Morphological and kinetic features of the lesion
viii
were extracted automatically, and then the feature selection step was utilized
to select the most relevant features to maximize the classifier performance. In
our study, the area under the receiver operating curve (AUC) is used as the
performance metric of the classifier, and our results are competitive with those
of previous studies.
The dissertation concludes by summarizing the contribution of this project
and suggesting the future directions of quantitative and highly automated
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1.1 Motivation and Research Goals
Breast magnetic resonance imaging (MRI) is the most sensitive imaging modal-
ity for diagnosing primary and recurrent breast cancer. Breast MRI outper-
forms other screening modalities for women at high risk of developing breast
cancer [64, 69]. Breast MRI has also evolved as a useful tool in staging of
breast cancer. Previous studies indicate that breast MRI is more accurate
than mammography and ultrasound in estimating tumor size [7, 33, 34, 56, 80].
Thus, breast MRI has promise for improving breast cancer management.
Breast MRI is performed with dynamic contrast-enhanced techniques, in which
the breast is scanned before, and after the administration of a contrast agent.
Dynamic contrast-enhanced (DCE) breast MRI provides a noninvasive assess-
ment of microcirculatory characteristics of tissues in addition to anatomical
information [113]. Traditional manual interpretation of DCE breast MRI is
time-consuming and tedious and can lead to oversight error due to the large
size of the four-dimensional data sets (three spatial dimensions plus time).
Manual interpretation of lesion morphological features and size is also subject
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to inter- and intra-observer variability [57, 99, 108]. Currently, the specificity
of breast MRI depends on the experience of the radiologist [59].
To facilitate the use of MRI for improving breast cancer care, there is a need
to develop an image analysis system to help interpret the images in a more
accurate, efficient, and consistent way. Another benefit of such a system would
be to reduce the high cost associated with breast MRI exams. Thus, the spe-
cific aims of this study are to:
(1) Develop an efficient lesion segmentation method to segment out the lesion
from the surrounding tissues on the first post-contrast breast MR image. This
step will lead to accurate delineation of the lesion such that morphological or
margin features of lesion can be extracted for subsequent lesion classification.
(2) Comparatively study the similarity metric in registering DCE breast MR
images to deal with intensity changes over time and motion effects across image
volumes acquired sequentially, accuracy and robustness of registration perfor-
mance will be assessed.
(3) Construct models to classify lesions as benign or malignant, based upon
the morphological parameters extracted from the segmented lesion and the
kinetic features extracted from the registered breast MR image series.
This study is significant because breast cancer is a major public health prob-
lem and the efficiency and accuracy of breast MRI interpretation need to be
improved. If successful, this study will enable the development of clinical
2
decision support systems for breast cancer diagnosis and management.
1.2 Outline of the Dissertation
The main body of this dissertation contains five chapters, chapter 2–6. Chap-
ter 2 reviews the breast imaging techniques, including commonly used ones in
current clinical practice and emerging techniques still in development. Chap-
ter 2 discusses extensively the principle of the dynamic contrast-enhanced
(DCE) breast MRI. Chapter 3 begins by reviewing the diagnostic guidelines
for interpreting breast MRI, and then discusses the needs and challenges that
arise in developing computational image analysis system for breast MRI ap-
plication. In chapter 3, the research goals and design methodologies of this
dissertation are outlined. In order to extract morphological features from the
segmented lesions, the lesion needs to be accurately segmented out from its
surrounding tissues. Chapter 4 utilized a probabilistic method to obtain an
optimal segmentation map based on several algorithmic segmentation outputs.
In evaluating performance of segmentation algorithms, we compared the algo-
rithmic segmentation results against manually segmented lesions, and further
assess the segmentation impact on subsequent classification stage. In order
to extract accurate kinetic features on DCE breast MRI, image registration is
needed to compensate motion across image volumes acquired sequentially. In
chapter 5, we comparatively assessed the similarity metrics in registering DCE
breast MR images. The performance of cross correlation(CC) coefficient, and
mutual information (MI) were studied in both rigid and non-rigid registra-
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tion schemes. Numerical results and statistical properties are reported. The
resultant image quality after registration is discussed both qualitatively and
quantitatively. Chapter 6 presents a classification system based upon quanti-
tative morphological and kinetic features in improving the specificity of breast
MRI. Both morphological and kinetic features of the lesion are extracted au-
tomatically, and then a feature selection step was utilized to select the most
relevant features to maximize the classifier performance. In our study, the area
under the receiver operating characteristic curve (AUC) is used as the perfor-
mance metric of the classifier, and our results are competitive with those of
previous studies. Chapter 7 summarizes the contribution of this dissertation
and suggests future directions regarding breast MRI analysis.
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Chapter 2
Breast Cancer and Breast Imaging
Breast cancer is the second leading cause of cancer deaths in American women
today. Approximately 200,000 new breast cancer cases are diagnosed and
about 40,000 women die from breast cancer in the United States. each year
[98]. The key to increasing survival is early detection and treatment of breast
cancer. Medical imaging is essential to breast cancer screening, diagnosis,
and treatment. Several imaging modalities, such as X-ray mammography, ul-
trasound, and MRI, are used for detection and diagnosis of breast cancer;
however, none of the modalities is flawless. An ideal breast imaging modal-
ity should detect, localize, and characterize abnormal tissues in the breast.
Current technologies cannot meet all three of these requirements in a single
imaging modality, so developers typically specialize in optimizing one goal at
a time [77]. Thus far, x-ray mammography is the first-line modality for breast
cancer screening. Other modalities, including ultrasound and MRI, are used
as adjunctive screening techniques [78]. In this chapter, we begin by briefly
discussing breast anatomy and breast cancer, and then discuss several com-
monly used breast imaging modalities, including X-ray mammography, DCE
breast MRI, and breast ultrasound. We also discuss three emerging breast
imaging techniques: digital breast tomosynthesis, breast CT, and breast PET.
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Figure 2.1: Sagittal section of a female breast. Picture courtesy of [73]
2.1 Breast Anatomy and Breast Cancer
2.1.1 Breast Anatomy
The breast is a mass of glandular, fatty, and fibrous tissues positioned on the
chest wall extending from the second to the seventh ribs. The breast consists
of glandular tissue, fibrous tissue, adipose tissue, lobes, blood vessels, lym-
phatic vessels, and nerves. Fig. 2.1 illustrates a sagittal section of a female
breast and the anterior thoracic wall.
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The breast has no muscle tissue. Immediately beneath the skin is a layer of
subcutaneous fat, and the fat (adipose tissue) surrounds the glands and de-
termines the shape and the size of the breast. Ducts and lobules comprise the
glandular tissue. There are about 15 lobes arranged in a circular pattern in
each breast, and each lobe consists of many lobules. The milk is produced
by the lobules and is transported by the ducts from the lobules to the nipple.
There are between 6 to over 20 duct openings around the nipple [58]. Fibrous
tissues are connective tissues surrounding the lobules and the ducts.
Regarding the vascular supply of the breast, the outer half of the breast is
supplied by the axillary artery extending from the armpit; the central and the
medial portions of the breast are supplied by the internal mammary artery
and its perforating branches. Most lymphatic channels in the breasts drain to
the axillary lymph nodes, and most lymph drainage passes through one or two
lymph nodes, the so called sentinel nodes [58].
2.1.2 Breast Cancer
Cancer derives from a collection of multiple genetic aberrations. It is believed
that breast cancer is a genetic disease and is caused by deoxyribonucleic acids
(DNA) changes. Such DNA changes can be inherited from family members
or acquired during one’s life. So far, the exact causes of acquired DNA muta-
tions remain unclear despite years of effort in studying breast cancer. However,
some risk factors have been identified including gender, age, genetic risk fac-
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tors, family history, race, dense breast tissue, and menstrual history. Some risk
factors relate with one’s lifestyle, such as having no children or having children
after a 30 years, use of birth control pills, hormone therapy, no breast-feeding,
alcohol usage, and obesity.
Breast lesions can be generally categorized by the major components in which
they develop [58]. Duct ectasia, cystic dilatations of the large duct, large duct
papillomas, and intraductal carcinomas are lesions of the major ducts. Hyper-
plasia, peripheral duct papillomas, and invasive ductal carcinoma are lesions of
the minor and the terminal ducts. Cysts, fibroadenomas, adenosis, phyllodes
tumors, and lobular carcinoma are the lesions of the lobule. Sarcomas arise
from the interlobular connective tissue.
There are several commonly used terms in breast cancer management to de-
scribe breast cancer, such as carcinoma, adenocarcinoma, carcinoma in situ,
invasive (infiltrating) carcinoma, and sarcoma. Carcinoma is used to describe
a cancer that begins in the lining layer of organs, such as the breast. Adenocar-
cinoma refers to the cancer that begins within the glandular tissue, including
the ducts and the lobules. Carcinoma in situ indicates the process is still in
the layer of cells where it started, including ductal carcinoma in situ (DCIS)
and lobular carcinoma in situ (LCIS). Invasive (infiltrating) carcinoma refers
to those cancers growing beyond the layer of cells where it began. Sarcomas
are cancers starting from connective tissues.
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Typically, hyperplasia, sclerosing adenosis, apocrine metaplasia, fibroadeno-
mas, intraductal papillomas, stromal fibrosis, radial scar, inflammatory changes,
atrophic changes, intramammary lymph nodes, and some phyllodes are benign
lesions. Invasive ductal carcinoma, DCIS, tubular carcinoma, invasive lobu-
lar carcinoma, and medullary carcinoma are malignant lesions. Breast cancer
typically spreads through lymphatic vessels, which transport cancer cells from
the breast to the lymph nodes, and then to distant locations in the body. The
tumor cells then colonize at the secondary sites, producing nests of tumor cells.
This process of tumor cells spreading is called metastasis, which is the main
process that leads to mortality in breast cancer patients.
The key to breast cancer survival is early detection and treatment. Breast
imaging techniques are critical for the early detection of breast cancer. Cur-
rently x-ray mammogram is the primary screening modality.
2.2 Mammography
Mammography is a radiographic examination technique that uses X-rays to
image breast tissue. The mammographic imaging unit consists of a x-ray tube,
a collimator, a compression system, and a detector. The attenuation of the x-
ray differs among various breast tissues, providing contrast on mammography
[58]. Denser tissue absorbs more X-rays and results in a bright region on the
image. Mammography attempts to identify the structural or morphological
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differences that can indicate the presence of cancer, such as masses, microcal-
cifications, and architectural distortions [16].
Mammography is a well-developed technology that offers high-quality images
at low radiation doses. Mammography can be used for both diagnostic and
screening applications. Screening mammography is used to detect abnormal-
ities in woman who are asymptomatic with no signs or symptoms to sug-
gest breast cancer. Screening generally includes two views of each breast,
the mediolateral oblique(MLO) projection and the cranio-caudal (CC) pro-
jection. Additional views, such as mediolateral (ML), inferosuperior oblique
(ISO), from below (FB), lateromedial oblique (LMO), and lateromedial (LM)
views, may provide further diagnostic value when abnormality is suspected on
the screening mammogram. Early detection by mammographic screening has
been shown to result in reduced mortality from breast cancer.
There are two major inherent limitations of x-ray mammography: the infor-
mation loss of visualizing a 3D structure in 2D projections and the lack of
functional insight regarding the biological processes of the breast tissue im-
aged. About 10-30% of tumors cannot not be detected by mammography
[8, 46, 54, 90]. It is particularly difficult to detect tumors in dense breasts and
breasts with implants and to identify residual and recurrent cancer using mam-
mography [31, 89]. It is also difficult to differentiate benign from malignant
lesions on mammography. The positive predictive value of mammography is
10
(a) Right CC (b) Left CC
(c)Right MLO (d)Left MLO
Figure 2.2: CC and MLO views of a patient diagnosed with invasive ductal
carcinoma with DCIS in right breast.
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low; only 10-30% of mammographically detected lesions subjected to biopsy
prove to be malignant [85]. Tumor size may also be inaccurately estimated on
mammography [7, 31].
Adjunctive modalities, including breast ultrasound and breast MRI, can over-
come the limitations of mammography to some extent.
2.3 Breast Ultrasound
Ultrasound is a well-established medical imaging technology that uses sound
waves to create images of tissue boundaries by detecting reflected sound waves
from internal tissues. When sonography is performed by emitting ultrasound
pulses into the target tissue, the sound wave reflects at the boundaries between
tissues with different acoustic properties. Since the depth of these boundaries
is proportional to the time intervals of reflection arrivals, ultrasound can be
used for imaging the tissue boundaries [77].
Ultrasound is excellent for differentiating solid masses from cysts, and it is
routinely used for cyst/solid differentiation. Also ultrasound is routinely used
for guiding interventional procedures, such as fine needle aspiration and core
needle biopsy [58].
Ultrasound does not use ionizing radiation, and it is safe and relatively pain-
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less. The United States Food and Drug Administration (FDA) has approved
ultrasound imaging as an adjunct to mammography for the detection of breast




The fundamental principle of magnetic resonance imaging is the nuclear mag-
netic resonance (NMR) phenomena [52]. The charged and spinning particles,
such as protons, have a magnetic dipole moment. When placed in an external
magnetic field, these charged and spinning particles rotate, in so called Larmor
frequency, along an axis either parallel or anti-parallel to the direction of ex-
ternal magnetic field. The energy level of those in parallel direction is slightly
lower than that of anti-parallel direction. I.I. Rabi, in the late 1930s, was
the first to apply radiofrequency (RF) pulse of just Larmor frequency to flip
nuclear magnetic dipole moments from one orientation to another orientation,
this phenomena is so called “nuclear magnetic resonance.” There are slight
more low-energy state spins than high-energy state ones, therefore tissue net
magnetization was induced when human body is placed in an external mag-
netic field. An RF pulse at Larmor frequency can flip the magnetization away
from the longitudinal direction (direction of external field) into the transversal
plane (perpendicular to external field). Then the longitudinal magnetization
13
recovers with a time parameter T1 (the longitudinal relaxation time); and the
transverse magnetization decrease with a parameter T2 (the transverse relax-
ation time). Usually T1 and T2 are unique biophysical characteristics of the
tissue and thus can be used to provide contrast between different tissues. In
the 1970s, pioneering contributions have been made leading to the applica-
tions of magnetic resonance in medical imaging. Of particular note were two
researchers, Paul Lauterbur and Peter Mansfield, who made fundamental con-
tributions. Paul Lauterbur introduced spatially-encoded magnetic field and
then resolved the source of the signal. Peter Mansfield showed how the radio
signals from the MRI can be mathematically analyzed as a useful image, and
he also developed a fast imaging technique called echo-planar imaging (EPI).
In 2003, Paul C. Lauterbur and Peter Mansfield shared the Noble Prize in
Medicine for their discoveries concerning MRI.
A basic MRI system consists of a static magnetic field, gradient fields (coils),
RF coils(transceiver), amplifiers to drive the gradient and RF coils, and a
computer to synchronize the pulse sequence and to process the signals. The
static magnetic field is a relatively constant and stable magnetic field. To
spatially encode the signal, gradient coils are used to modulate the magnetic
field strength as a function of space and time. MRI primarily images the NMR
signals from the hydrogen nuclei of the tissue. By applying a 3D encoded mag-
netic field, MRI enables a truly 3D examination of the breast tissues. However,
when first imaging breast using MRI technique twenty years ago, the relax-
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ation times of normal breast tissue and cancer were not sufficiently different
[58], therefor breast MRI without intravenous contrast material does not pro-
vide sufficient sensitivity or specificity; and non-contrast enhanced breast MRI
alone is not recommended in evaluating for breast cancer (Fig. 2.3).
2.4.2 Angiogenesis and Dynamic Contrast-Enhanced Breast MRI
The need to image tissue function is the driving force behind the development
of DCE MRI. Functional imaging is required in order to recognize the dis-
tinctions between tumors and normal tissue that exist at the molecular level,
such as differences in cellular composition, permeability, and microvessel den-
sity. The use of contrast agents in MRI enables the visualization of functional
changes, particularly angiogenesis, when dynamic MR images are acquired.
Angiogenesis is a sequential processes beginning with the tumor cells and host
cells releasing angiogenic molecules, such as vascular endothelial growth factor
(VEGF), to stimulate the endothelial cells to form new small vessels [115]. Tu-
mor cells rely on these capillary sprouts to bring nutrition and oxygen supplies,
and carry away the waste materials. Usually, benign neoplasms are sparsely
vascular and slow-growing, while malignant neoplasms are highly vascular and
fast-growing. Consequently, tumor microcirculation differs profoundly from
that of normal organs in three ways: a) in the flow characteristics and some-
times the blood volume of the microvasculature; b) in microvascular perme-
ability; and c) for many malignant tumors, in the increased fractional volume
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Figure 2.3: Axial, coronal, and sagittal views of a non-contrast enhanced T1-
weighted pre-contrast 3D breast MRI
of extravascular extracellular space (EES).
In a DCE MRI exam, a contrast agent such as gadolinium diethyltriamine-
pentaacetic acid (Gd-DTPA) diffuses into the extravascular extracellular space
(EES) via the capillaries, accumulates in the tissues with high vascularity, sub-
sequently leaks back into the vascular space, and is eventually excreted from
the body (Fig. 2.4). The diffusion process is governed by the kinetic proper-
ties of the target tissues. The concentration of the contrast agent alters the
relaxation time of the water protons in the surrounding tissue; thus, the accu-
mulated amount of the contrast agent around the targeted tissue is reflected
in the signal intensity. As there is contrast agent uptake and washout over
time, dynamic MR images are acquired along the time. In DCE MRI, pulse
16
Figure 2.4: Illustration of a compartment model demonstrating exchange of the
contrast agent between the blood plasma and the extravascular extracellular
space (EES). The contrast agent exchanges from the plasma to the EES at
rate Ktrans and from EES to plasma at rate kep. The relationship between
those two rates is governed by: kep =
Ktrans
ve
where ve is the fraction of tumor
space occupied by the EES.
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Figure 2.5: An image intensity curve across time for the voxel centered by
the red circles. The horizontal axis represents time while the vertical axis
represents signal intensity.
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sequences can be chosen so that the resulting images are selectively sensitive to
different vascular and kinetic characteristics. With appropriate use of contrast
agents, dynamic T1- and T2-weighted images can be acquired. The net effects
on the post-contrast image intensities of targeted tissues in the T1-weighted
and T2-weighted images are opposite [25, 72]. On T1-weighted images there
is ”enhancement”, while on T2-weighted images there is ”darkening” [25, 72].
However, the term dynamic contrast-enhancement is used in either case. T1-
weighted images have been most commonly used in assessing breast tissue.
Unless otherwise stated, the DCE breast MR images discussed in this dis-
sertation are T1-weighted images. Essentially, the dynamic image intensities
reflect the physiological nature of the targeted tissue. For any location in the
image, the dynamic signal intensities can be viewed as a multi-dimensional
signal, usually referred to as the kinetic enhancement curve (Fig. 2.5). Previ-
ous studies have shown that the kinetic enhancement curves of malignant and
benign lesions are usually different. Thus, in addition to the morphological
features of the lesion, kinetic features are recommended for use in determining
the pathological nature of the lesion.
2.4.3 MRI Contrast Agent and Safety Concern
In 2006, a rare disease, known as nephrogenic systemic fibrosis or nephro-
genic fibrosing dermopathy (NSF/NFD), was reported to occur in patients
with moderate to end-stage kidney disease after they had a MRI or magnetic
resonance angiography (MRA) examination with a gadolinium-based contrast
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agent. Consequently, new governmental guidelines have been issued, and exist-
ing MRI procedures have been revised on using contrast agents in MRI. The
International Society of Magnetic Resonance in Medicine maintains a web-
page with a collection of materials and updated information on NSF and MRI
safety, to which we recommend interested readers for detailed and updated
information on this topic [1].
Though it is not determined yet on the causative relationship between NSF/NFD
and gadolinium-based contrast agents, the US FDA [2] has requested the man-
ufacturers to include a new boxed warning on the product labeling of all
gadolinium-based contrast agents that are used for enhancing MR images. The
requested warning states that “the patients with severe kidney insufficiency
who receive gadolinium-based agents are at risk for developing a debilitating,
and potentially fatal disease known as NSF.” The warning also states that
“patients just before or just after liver transplantation, or those with chronic
liver disease, are also at risk for developing NSF if they are experiencing kid-
ney insufficiency of any severity.”
The FDA release [2] further states that patients should be screened for kidney
problems prior to the administration of a gadolinium-based contrast agents.
The implementation of appropriate procedures is vital to avoid and prevent
accident/incidents. The FDA release [2] requests that the the contrast agent
dose not exceed the recommended dose and that enough time elapse be en-
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Contrast Agent Marketed as Manufacturer
Gadobenate Dimeglumine MultiHance Bracco Diagnostic Inc., Princeton, NJ
Gadodiamide Omniscan GE Healthcare, Chalfont St. Giles, U.K.
Gadopentetate Dimeglumine Magnevist Bayer Schering Pharma, Berlin, Germany
Gadoteridol ProHance Bracco Diagnostic Inc., Princeton, NJ
Gadoversetamide OptiMARK Mallinckrodt, Inc., Haelwood, Mo.
Table 2.1: Five gadolinium chelates approved by US FDA for use in MRI scan
sured before injection of the contrast agent again.
In the United States, there are five FDA-approved gadolinium-containing con-
trast agents for use with MRI. Some clinical data suggest that the linear and
the nonionic agents, such as Gadodiamide, are more likely to be associated
with NSF [10]. Currently, it is not yet clearly determined whether gadolinium-
based contrast agents can cause NSF. However, precautions should be taken
when using the five gadolinium-based contrast agents in patients [96].
At The University of Texas M. D. Anderson Cancer Center (UTMDACC) , the
practice of administering gadolinium-based contrast agents has been revised
according to increased awareness regarding NSF. At UTMDACC, patients are
questioned whether they have history of renal disease/failure/dialysis or acute
renal insufficiency of any severity due to the hepato-renal syndrome or if they
are in the perioperative liver transplantation period. Those with no or min-
imal risk factors can proceed with standard MRI protocols. Those at risk
for developing NSF need to be carefully checked before MRI scan with the
21
administration of a gadolinium-based contrast agent. The glomerular filtra-
tion rate (GFR) is an indication of renal function and used in determining
the chronic kidney stage(CKD). A GFR value greater than 60ml/min/1.73m2
will be considered as normal GFR or Stage 1-2 CKD; these patients can pro-
ceed with standard MR scans but not be injected with Omniscan. Those with
GFRs between 30 and 59ml/min/1.73m2 are considered as Stage 3 CKD; these
patients should be reviewed by radiologist individually and no Omniscan ad-
ministered, but low risk contrast agents, such as Magnevist, or ProHance, or
MultiHance, can be considered. Those with GFR less than 29ml/min/1.73m2
are considered as Stage 4-5 CKD; these patients need to be carefully reviewed
according to the following procedures: the referring or radiology physician de-
termines the Gd-based MRI scan is medically necessary, then a renal physician
or nephrologist should be consulted and a radiologist will consider the results
of this consult in assessing the risks and the benefits to the patients. Also
only low risk gadolinium-based contrast agents can be used and followed by
hemodialysis within 2 hours of completion of MR study for the patients at
Stage 4-5 CKD.
In additional to breast MRI, other imaging modalities, such as digital breast
tomosynthesis and breast computed tomography (CT), can also obtain 3D
images of the breast.
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2.5 Digital Breast Tomosynthesis and Dedicated Breast
CT
Digital breast tomosynthesis (DBT) and Breast CT are two new breast imaging
modalities. The setup of DBT is essentially a modification of the conventional
mammogram machine [83]. In a DBT scan, the breast is positioned the same
way it is in a conventional mammogram, and the X-ray tube moves in an arc
around the breast. Multiple X-ray images of each breast from different angles
are acquired and then sent to a computer to reconstruct a volumetric image.
The total radiation dose for a DBT scan is slightly higher than that for con-
ventional mammogram. The prototype DBT machines have been made by
manufacturers for clinical evaluations. These DBT units have dual functions
of performing both digital mammograms and breast tomosynthesis with the
same machine.
Very recently, dedicated breast computed tomography (CT) systems capable
of cone-beam CT of the breast have been developed [11, 116]. In cone-beam
breast CT setup, the patient lies prone and breasts are put into the openings
of the bed, both x-ray source and flat panel detector system simultaneously
rotate 360◦ around the breast. In cone-beam CT scan, only breasts expose
to radiation and the total radiation dose comparable to conventional mammo-
gram [11]. Cone-beam breast CT can provide a true 3D image with isotropic
resolution. Total 500 projections are acquired and then sent to computer to
reconstruct a 3D image. In the initial breast CT clinical trial, the breast CT
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does better in visualizing masses compared to mammography, but has chal-
lenge in imaging microcalcifications [66].
Both digital breast tomosynthesis and breast CT are promising techniques and
are still under development; larger clinical trials are needed to determine their
future roles in clinical settings.
2.6 Positron Emission Mammogram
Clinical and small-animal positron emission tomography (PET) have expanded
significantly during the past decade. PET is a molecular imaging technique
that obtains images of molecular events in living subjects by localizing the
radiotracers. The principle of PET imaging is based on the abnormalities
of cellular function in tumors. Properly designed radiotracers can be used
to probe tumor biology. The most commonly used PET radiotracer is 18F-
fluorodeoxyglucose (FDG) as tumor cells have a higher rate of glucose use.
When injected into the bloodstream, FDG is taken up by the cancer cells at a
higher rate than normal cells; thus, image contrast is obtained between tumor
region with FDG and the neighboring tissues.
Previous studies using FDG PET to detect breast cancer showed that the sen-
sitivity of FDG PET in detecting breast cancer was limited [68, 111]. PET
may be helpful in breast cancer staging; however, previous study results are
mixed and inconclusive [30, 68, 111]. Some studies have suggested that FDG
24
PET can be helpful in detecting distant metastases from breast cancer and in
monitoring response to therapy [65, 68].
A dedicated breast PET scanner, also called positron emission mammogra-
phy (PEM) has been developed in recent years. Gentle compression, in con-
trast to the firm compression in x-ray mammography, is applied to immobilize
the breast during the PEM scan. PEM generates a 3D volume with a high-
resolution ( 2mm) in-plane image matrix. Currently, the PEM scanners do
not have accompanying CT systems for attenuation correction. Therefore cur-
rent PEM system can only provide qualitative imaging instead of quantitative
imaging that is available with conventional PET/CT scanners. Dedicated
breast PET/CT scanners are still in the prototype stage.
2.7 Summary of Current Breast Imaging Modalities
Currently, x-ray mammogram is the primary breast imaging modality, and
ultrasound and breast MRI are two most often used adjunctive modalities.
The roles of other imaging modalities in breast cancer detection and diagnosis
are rapidly evolving. Newer ultrasound methods such as 3D ultrasound, and
nuclear medicine methods such as positron emission tomography (PET), are
all exciting areas of development in breast imaging. Each of these alternatives
are being sought in order to overcome at least one of the two major inherent
limitations of x-ray mammography: the information loss of visualizing a 3D
structure in 2D projections and the lack of functional insight regarding the
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biological processes of the breast tissue imaged. In Table 2.2, we provide a
comparison of several breast imaging techniques.
In the near future, mammography will still be the first line screening imaging
choice. However, the inherent limitations of mammography as a radiographic
planar image will still exist even in digital mammography, therefore it is nec-
essary for other breast imaging techniques to accomplish more than current
mammograph can provide. Note that breast tomosynthesis technique is still
in early development stage and breast CT is still in its infancy, the efficiency
and future role of these two techniques are still unclear yet. Breast MRI will
be used in screening women at high risk for developing breast cancer, and will
be routinely used for staging. In addition, breast MRI is used for monitoring
treatment response and for surveillance for disease recurrence. In the next 10
years, we predict that X-ray mammography will still be the primary breast
screening modality, and breast MRI will be increasingly used an adjunct to
mammography. More clinical trial results are needed in order to determine
the roles of DBT and breast CT in breast cancer diagnosis and staging.
26
\ Mammo MRI Ultrasound Tomo CT PET
Sensitivity 70–90% 95-98% 2D NA NA NA
Specificality < 50% 20-95% 2D NA NA NA
Ionization Yes No No Yes Yes Yes
Dimension 2D dynamic 3D 2D or 3D 3D 3D 3D
Principle density physiology impendence density density physiology
Compression Yes No No Little No Yes
Scan time 10 mins 30 mins 10 mins 20 mins 20 mins 20 mins
Scan Cost(∼) $200 $1500 $200 NA NA NA
Equipment
Cost(∼)
$200K $2000K $40K $ 300K $ 400K $500K
Table 2.2: Summary of breast imaging modalities
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Chapter 3
Computational Image Analysis for Breast MRI
High cost and low specificity are two factors impeding wide use of breast MRI
in current breast cancer care management. In addition to the scanner and
material cost, high interpretation cost is another factor causing the high cost
of breast MR exams. Since breast MRI generates 4D data, substantial effort
is needed by radiologists in order to interpret the large amount of imaging
data. Breast MRI is a relatively new technique, many radiologists do not have
sufficient training or experience to interpret the breast MR images. Thus the
specificity of breast MRI exam varies from site to site depending on the ex-
perience level or skill of radiologists. To facilitate the use of this advanced
imaging modality for improving breast cancer care, there is a need to develop
an image analysis system to help interpret breast MRI in a more accurate,
efficient, and consistent way.
This chapter begins by reviewing the diagnostic guidelines in practice for in-
terpreting breast MRI, then discusses the needs and the challenges that arise
in developing a computational image analysis system for breast MRI applica-
tions. Then research goals and design methodologies of this dissertation are
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outlined to prototype and evaluate the algorithms. The last section of this
chapter gives a description of the breast MR imaging data used in our studies.
3.1 Diagnostic Criteria for Interpreting Breast MRI
There are no universal interpretation criteria for breast MRI; however, some
guidelines have been proposed [60, 79, 95]. The American College of Radiology
[79] provides a standardized lexicon to describe findings on breast MRI, and
suggests some criteria for interpreting breast MRI examinations. Experienced
radiologists have also summarized guidelines based on their own expertise [60].
The first step in interpreting a breast MRI is to determine the configuration of
the lesion, namely if the lesion is (a) a mass, (b) a non-mass-like enhancement,
or (c) a “focus” [60, 79].
A “mass” is defined as “a space occupying tumor that has three dimensions”
[79]. A mass can be either a benign tumor (e.g., fibroadenoma) or a malignant
tumor (e.g. breast cancer). Generally, masses with irregular shapes are more
likely to be malignant than those with round, oval, or lobulated shapes [60, 79].
The margin of a mass is also indicative of its pathological classification. The
margin of the mass can be described as smooth, irregular, or spiculated. A
spiculated margin is suggestive of a malignant tumor, while a smooth margin
is suggestive of a benign lesion. However, the accuracy of the margin informa-
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tion is subject to the spatial resolution of the MR image. Margin information
extracted from a low-resolution image may not be as accurate as that from
a high-resolution image [63]. In addition to shape and margin features, the
internal enhancement pattern within the lesion provides important differential
diagnostic information. The internal enhancement patterns can be described
as: (a) dark/enhancing internal septations, (b) homogeneous, (c) heteroge-
neous, (d) rim enhancement, or (e) central enhancement. Generally, dark
internal septations and homogeneous enhancement patterns are suggestive of
benign lesions, while heterogeneous, rim enhancement, and enhancing internal
septation are typical of malignant tumors [60]. Dynamic contrast-enhanced
breast MRI not only provides internal enhancement patterns for further as-
sessment of the lesion, but also provide powerful differential diagnostic criteria
through kinetic time curve analysis. Previous studies have shown that the
kinetic enhancement curves of malignant and benign lesions are different (see
Fig. 3.2 ) [62]. In evaluating kinetic time curves, the early wash-in rate and
the delayed-phase enhancement patterns are assessed in a small region of in-
terest (ROI) containing the brightest enhancement on the first post-contrast
image. It is believed that the early wash-in rate of malignant tumors is higher
than that of benign lesions. The delayed phase enhancement pattern is an-
other feature that can be used to distinguish benign from malignant lesions.
A persistent pattern is suggestive of a benign lesion, while a washout pattern
is suggestive of a malignant lesion. A plateau pattern may be found in both
benign and malignant lesions [95].
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A “non-mass-like enhancement” finding on breast MRI can be due to an in-
traductal tumor or a benign process, such as focal adenosis, hormonal stimu-
lation of normal tissues, or inflammatory changes/mastits. Rarely, non-mass
enhancement may be due to an invasive lobular cancer [60]. Unlike a “mass”,
the shapes and borders of a “non-mass-like enhancement” cannot be described.
The distribution pattern of the enhancement is an important differential in-
dicator. The distribution pattern can be described as “segmental,” “ductal,”
“linear,” “focal area,”“regional enhancement,” or “diffuse enhancement” (en-
hancement in multiple regions). Usually, segmental or ductal enhancement
patterns are indicative of intraductal tumors. In addition to the enhance-
ment distribution pattern, the internal enhancement pattern within a region
of ”non-mass-like enhancement” is another differential diagnostic indicator.
The internal enhancement pattern can be described as homogeneous, hetero-
geneous, stippled, or clumped. The clumped and stippled patterns are typically
due to ductal carcinoma in situ. However, the internal enhancement patterns
of a “non-mass-like enhancement” are less indicative than those of a “mass”
finding [60]. Besides the distribution patterns and internal enhancement pat-
terns, symmetry of a “non-mass-like enhancement” is another differential fac-
tor. Asymmetric non-mass-like enhancement findings are more likely to be
malignant than symmetric ones. The kinetic time curves of ”non-mass-like
enhancements” should be assessed in a manner similar to the way that masses
are analyzed.
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Figure 3.1: Mass Pattern. Reproduced from Fig. 3 of [95]
.
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The third type of finding on breast MRI is a “focus”, which refers to a small
enhancing area less than 5mm [79]. Due to its tiny size, the shape and margins
of a ”focus” can not assessed, and its kinetic information may be compromised
due to partial volume averaging with its surrounding tissue [79]. Therefore,
it is usually not possible to further classify ”focus” findings on breast MRI
[60, 79], and they must be further evaluated based on other data.
This dissertation project will employ mass lesions only since most cancers
present as masses on breast MRI exams [109].
3.2 Computer-aided System for Breast MRI
The accuracy of image-based diagnosis is determined by both image acquisi-
tion and image interpretation. Consequently, the use of computer-aided detec-
tion (CADe) and computer-aided diagnosis(CADx) systems have been rapidly
developed at several academic and industry sites for the purpose of aiding ra-
diologists in interpreting medical images. CADe systems are intended to aid
radiologists in the process of detecting and localizing abnormalities on medical
images, and as such they help overcome perceptual errors such as oversight.
CADx systems are intended to aid radiologists in the process of predicting
the pathological nature of a lesion and to assist in selecting an appropriate
next action, typically biopsy or follow-up imaging. Thus, CADx systems can
help avoid missed cancers and obviate benign biopsies. It is important to rec-
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(a) Early phase kinetic curve pattern
(b)Intermediate and late phase kinetic curve pattern
Figure 3.2: Ideal kinetic enhancement curve patterns of benign and malignant
breast lesions on DCE MRI. The horizontal axis represents time and the ver-
tical axis represents signal intensity. The curves labeled types Ia and type Ib
are typical of benign lesions while those labeled type II and type III are typical
of malignant lesions. (b) reproduced from [62]
.
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ognize that CADe/CADx systems are designed to assist radiologists, not to
perform autonomous diagnosis, although early experiments focused on the in-
dependent performance of CADe/CADx systems [113]. In breast imaging, the
majority of work to date in CADe/CADx has focused on x-ray mammography
[93] computer-aided detection techniques that use image analysis algorithms to
detect suspicious areas, initial studies show CADe technology may reduce the
number of missed cancers on mammography and can significantly enhance the
performance of general radiologists [43, 78]. CADx systems for mammography
are not yet in routine clinical use, but these systems have been the subject of
numerous research studies.
The core of CADe/CADx systems is the computational image analysis algo-
rithm(s), and the entire CAD system is the implementation of image analy-
sis algorithms in a specific computer language. Two common medical image
analysis modules are image segmentation and image registration. Image seg-
mentation is to automatically identify relevant structures in the images. Im-
age registration is to establish correspondence between the images acquired
using different imaging modalities (inter-modal registration) or at different
times (intra-modal registration). In addition, image classification and ma-
chine learning techniques can improve the specificity of abnormal findings by
predicting that a detected lesion is benign or malignant. Other information,
such treatment options, can be predicted based on the quantitative imaging
features as well.
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The high cost and varying specificity of breast MRI are two factors restrict-
ing its use in routine clinical practice. CADe/CADx systems for DCE breast
MRI are needed to enable more efficient and accurate interpretation of breast
MRI exams. In fact, improving efficiency is the primary goal of current
commercial systems for computer-aided DCE breast MRI interpretation. To
the best of our knowledge, there are currently four commercial software sys-
tems for aiding with DCE breast MRI interpretation that are approved by
the FDA: CADstream (Confirma, Kirkland, WA), fTP (CAD Sciences, New
York, NY), DynaCAD (Invivo, Orlando, FL), and OnCAD (Penn Diagnostics,
Rockville, MD). While these systems represent an important step in breast
MRI CADe/CADx development, one should recognize that they are currently
more limited than their more established counterparts in x-ray mammography.
In particular, all systems currently on the market are visualization software
tools that aim at improving efficiency only. At the present time, no commercial
system attempts to improve the specificity of breast MRI exams, and there are
no standardized or automatic approaches for analyzing or interpreting breast
MR images. Thus, there is a great need for a CADx system for DCE breast
MRI.
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3.3 Research Design and Methods
In order to develop an effective CADx system for breast MRI, research is
needed on the necessary algorithmic components (including lesion segmen-
tation, image registration, and lesion classification) and the development of
common metrics and methods for evaluation. The goals of the this disserta-
tion are to develop image analysis methods that ultimately would improve the
performance of each of the major algorithm components that would be needed
in a breast MRI CADx system. Diagnostic criteria used in current clinical
practice suggest that both morphological and kinetic features of lesions be
evaluated in making diagnosis and treatment decisions [60, 79, 95]. Thus, the
lesion needs to be accurately segmented, not simply localized, so that the mor-
phological features can be measured. Parallel to the lesion segmentation step,
the kinetic features of the lesion need to be extracted accurately as well so
as to provide additional differential diagnostic information. In order to ex-
tract accurate kinetic information, an image registration step is necessary to
spatially align the voxels across sequentially collected breast MRI volumes to
ensure accurate time curve signal representation at each spatial location of
the lesion. With morphological and kinetic features quantitatively measured,
a classification model can be constructed to determine whether a lesion is more
likely to be benign or malignant.
A flow chart is described in 3.3 to illustrate the image analysis pipeline.
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The image database used in this study was collected retrospectively under a
research protocol approved by institutional review boards of both The Univer-
sity of Texas at Austin and The University of Texas M. D. Anderson Cancer
Center. Women between the ages of 21 and 75 years who underwent breast
MRI examinations at The University of Texas M. D. Anderson Cancer Cen-
ter between Arpil 01, 2006 and April 15, 2007 were eligible for this study.
Images were obtained with fast spoiled gradient recalled sequence (TR/TE=
milliseconds, echo time varies from 1.6 to 2 milliseconds, flip angle = 15◦).
Patients were scanned while in the prone position on a 1.5-Tesla MRI scanner
(General Electric Medical Systems, Milwaukee,WI,USA). After acquisition of
the precontrast volume image, a gadolinium-based contrast agent was injected
intravenously by a power injector, and followed by a saline injection. Four
postcontrast series were obtained, with an interval about 120 seconds. Each
image matrix had 256 ×256 pixels and the slice thickness was 1.5 mm (3 mm
thickness acquired, 1.5 mm spacing after slice interpolation).
A query search resulted in a total 363 patients with a total of 390 breast MRI
exams. After reviewing the report from each MRI examination, we excluded
patients from our study for any of the following reasons:
(1) There was no lesion found on the breast MRI examination;
(2) The patient received chemotherapy or radiation therapy prior to
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the examination;
(3) The lesion displayed on the breast MRI was too small (smaller than
5 mm);
(4) The patient was diagnosed with inflammatory breast cancer;
(5) The patient stipulated that her medical records be reviewed only
by those directly involved in the patient’s care; (such cases were dropped
immediately without reviewing the patients’ imaging reports).
(6) The patient was unable to maintain the prone position during the
examination, or the examination was interrupted due to the patient’s discom-
fort, or the entire exam was incomplete.
We studied a total of 79 mass findings on breast MRI. Of these 79 masses, 50
were malignant, and 29 were benign.
We determined whether a lesion was malignant based on the following criteria:
(1) MRI/ultrasound guided needle core biopsy proved the lesion to be malig-
nant; or (2) Fine needle aspiration cytology proved the lesion be malignant;
We determined whether a lesion was benign based on the following criteria:
1) pathology results proved the lesion to be benign; or (2) follow-up mam-
mograms, breast MRI, or ultrasound after at least twelve months showed the




Diagnostic criteria used in current clinical practice suggest that both mor-
phological and kinetic features of lesions be evaluated in making diagnosis
and treatment decisions [60, 79, 95]. The segmentation step is crucial because
errors at this stage impact subsequent morphological feature extraction and
classification. Thus, the lesion needs to be accurately segmented from the sur-
rounding tissues, not simply localized, so that the morphological features can
be accurately measured and evaluated.
This chapter concerns lesion segmentation on breast MRI. We begin by re-
viewing previous lesion segmentation work in breast MRI. In our study, we
utilize a probabilistic method to obtain an optimal segmentation map based
on several algorithmic segmentation outputs. In evaluating the segmentation
performance, we further assess the impact of the resulting segmented lesions
on subsequent classification performance.
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4.1 Previous Segmentation Methods of Breast MRI
Image segmentation is a well-explored field. The purpose of image segmenta-
tion is to partition the image into disjoint sub-regions, and each resulting sub-
region represents a different object. Several previous publications are directly
related to lesion segmentation on breast MRI. Arbach et al. [4] segmented the
subtraction image, which is generated by subtracting the pre-contrast image
from the first post-contrast image. The segmentation in Hayton’s work was
based on thresholding the enhancement rate of the first two images in the series
[50]. Gihuijs et al. [45] developed a seeds-based volume-growing algorithm to
segment the lesion from the ROI (region of interest) using thresholds derived
from the image histogram. Petroudi et al. [86] proposed a Gaussian mixture
model for dynamic breast MRI data, in which the relationships between voxels
are modeled by a Markov random field (MRF) and the mixture parameters
are iteratively updated based on K-means initialization. However, K-means
initialization is not stable and not recommended in general. Chen et al. [21]
proposed an automatic lesion segmentation method based on a fuzzy c-means
technique to partition all voxels within the ROI to either lesion or non-lesion
classes, and morphological processing was applied to generate a smooth seg-
mentation map. Wu et al. [114] proposed an interactive lesion segmentation
method by generating a maximum a posteriori (MAP) estimate of the class
membership (lesion vs. non-lesion) for each voxel within the ROI. The prior
distribution of the class membership in [114] was modeled as a multi-level lo-
gistic model, a MRF model in which the class membership of each voxel is
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assumed to depend upon its nearest neighbors only.
Among these methods, the segmentation is performed on raw breast MR se-
quences directly in [4, 21, 45]; thus, the segmentation results are compromised
by the motion displacement across the image series. Though the lesions are
segmented on the motion-corrected images in [50, 114], the performance of im-
age registration is difficult to validate and it is not expected to compensate
completely for all motion distortions. Since the segmentation algorithms in
[4, 21, 45, 50, 86, 114] use two or more image sequences of the raw or the regis-
tered MRI sequences, the segmentation results are compromised, more or less,
by motion distortion.
4.2 The Segmentation Scheme in Our Study
Lesions, along with other tissues, such as ducts, lymph nodes, and blood ves-
sels, enhance on post-contrast images [71]. Thus, enhancement alone may lead
to a false positive detection; therefore a more sophisticated algorithm would
be required for lesion detection. Rather than attempting to automate the de-
tection step, we assume that the ROI has already been detected by the human
reader. In our study, we only investigate segmenting the lesion from its sur-
rounding tissues within the manually pre-defined ROIs.
Since DCE breast MRI generates 4D imaging data, one may choose to segment
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lesions using 4D. However, due to motion, the same location at different times
may not be associated with the same physical object. In order to eliminate
the impact of motion distortion on segmentation performance, we perform seg-
menting the lesion from the surrounding tissues on the first post-contrast im-
age, which also provides strong contrast between the lesion and the non-lesion
tissues. This practice is consistent with the American College of Radiology’s
guidelines [79] which suggest that lesion measurement be performed on the
first post-contrast image.
4.2.1 STAPLE Algorithm to Optimize the Segmentation Map
A single segmentation algorithm may not prove to be consistently superior to
all other methods given the complexity of breast MR images. If a set of au-
tomatic segmentation generators provide complementary information, it may
be beneficial to combine their assessments. Since a large number of image
segmentation algorithms have already been developed, this study focuses on
optimizing the segmentation results by computing a probabilistic segmenta-
tion based on a collection of algorithmic segmentation maps, such as those
generated by threshold based segmentation, the fuzzy C-means segmentation
algorithm, and the mean shift segmentation algorithm.
Recently the STAPLE (simultaneous truth and performance level estimation)
algorithm was introduced to combine segmentations from multiple human
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raters or automated algorithms in order to compute a probabilistic estimate
of the true segmentation map [106]. In the STAPLE formulation, the expert
segmentation decision at each voxel is known information, and the hidden
true segmentation is a binary variable but unknown for each voxel. The per-
formance level, or quality, achieved by each segmentation (either human or
algorithm) is represented by sensitivity and specificity parameters. The STA-
PLE algorithm estimates the unknown true segmentation map by using the
expectation- maximization (EM) algorithm. Detailed formulation of the STA-
PLE algorithm will be discussed in the following paragraph.
The notations here follow the ones in the paper by Warfield et al. [106]. Con-
sider an image of N voxels, and the task of segmenting a structure in that
image by indicating the presence or the absence of the structure (lesion in
our study) at each voxel. Let p = (p1, p2, . . . , pR)
T be the sensitivity param-
eter, with each element characterizing one of R segmentations; and likewise
q = (q1, q2, . . . , qR)
T be the specificity parameter. Let matrix DN×R denotes
the binary decisions made by each segmentation at each voxel of the image.
The hidden binary true segmentation vector, TN×1, denotes each voxel as 1
(lesion) or 0 (non-lesion).
The STAPLE method formulates a probabilistic estimate of the true segmen-
tation as an optimal combination of the segmentation results D. Then the goal
is to find the optimal performance level parameters (p∗, q∗) that maximize the
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following complete data log likelihood function:





|D, pk−1, qk−1] (4.1)
The performance parameters, and a probabilistic estimate of the true segmen-
tation, can be optimized using the EM algorithm iteratively. The first step
of each iteration is to estimate the conditional probability of the true seg-
mentation given the expert decisions and the previous performance parameter
estimates (see Equation (4.2)), and the second step updates the estimation of
the performance parameters (see Equation (4.3)).
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∏
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4.2.2 The Automatic Segmentation Algorithms
As described above, the STAPLE algorithm is based on several manual or
algorithmic segmentation results. The segmentation maps on which the STA-
PLE algorithm utilizes are obtained by the following segmentation methods:
1. Threshold-based segmentation: Global thresholding is a simple ap-
proach of image segmentation if there are multiple clearly separated peaks
in the image histogram. This method labels each pixel of the image based
on the intensity value. Since the lesion is enhanced after the injection of the
contrast agent, threshold based methods could be used for our application.
We used an automatic method [81] to determine the threshold that maximizes
the separability of the resulting sub-regions. This method is nonparametric
and unsupervised in the sense that no a priori knowledge about the image is
needed.
In our experiments, the voxels with intensity value above the threshold are con-
sidered as the lesion. However, segmentation on the basis of intensity alone
lacks spatial coherency. There maybe some small holes inside the segmented
lesion caused by necrosis or image inhomogeneity. A morphological operation
is performed to fill in these small holes.
2. Fuzzy C-means Segmentation
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The Fuzzy C-means (FCM) algorithm was formulated by modifying the ob-
jective function of the standard FCM algorithm to compensate for intensity
inhomogeneities and to allow the labeling of a pixel (voxel) to be influenced by
the labels in its immediate neighborhood. The neighborhood acts as a regular-
izer and biases the resulting segmentation map toward piecewise-homogeneous
labeling; such a regularization is useful in segmenting scans corrupted by salt
and pepper noise. In our experiments, the initial segmentation map was ob-
tained by the automatic threshold algorithm discussed above.
The basic idea of the FCM algorithm can be summarized below. The standard







upik‖xk − vi‖2 (4.4)
where where vi are the cluster centers and the partition matrix uik denotes a
likelihood of data xi belonging to the cluster i and the elements are subjected
to the following constraint
∑c
i=1 uik = 1, 0 ≤ uik ≤ 1. In [3], Ahmed et al
proposed a modification to (4.4) by introducing a term that allows the labeling
of a pixel (voxel) to be influenced by the labels in its immediate neighborhood
















‖xk − vi‖2) (4.5)
where Nk denotes data α, and NR is the cardinality of the window Nk.
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3. Mean-shift Segmentation
Ideally, spatial information should be incorporated into a segmentation scheme.
After pre-processing an input image to be segmented, a pixel/voxel in the im-
age can be mapped into a point in the feature space (joint spatial-intensity
space). Significant features will be grouped together and form a denser region,
namely a cluster, in the feature space. In this manner, image segmentation
can be posed as a clustering task in the feature space that is derived from the
input image [28].
Mean shift is a data-clustering method that searches the modes of the un-
derlying probability density and clusters the data without estimating density
explicitly [23, 26, 27, 40]. This method is based on density estimation theory
and its efficient gradient estimation [35, 38, 84, 97]. Even though the mean
shift method was first studied in 1975 [38], only recent work [23, 26, 27] has
exploited the properties of mean shift for clustering and image segmentation.
The mean shift method has been demonstrated to be successful for several
segmentation tasks [26–28]. Here we discuss briefly the basic principles of the
mean shift method, and we refer the interested readers to [23, 26, 27] for more
details.
Assume that for each data point xi ∈ Rd, i = 1, . . . , n, the sample point
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where the kernel K(x) is the multivariate kernel and h is the window band-
width, also called the smoothing parameter. A large value of h provides the
global structure of the data, while small window radii h reveal the local struc-
ture. Previous experiments have demonstrated that the segmentation is not
very sensitive to the choice of bandwidth h [28].
In our experiments, each breast MRI image is represented as a 3-dimensional
lattice of scalars (voxels). The space of the lattice is referred as the spatial
domain while the image intensity information is referred to as the range do-
main. In implementing the mean shift algorithm for lesion delineation on
breast MRI, we want to group into the same cluster only those voxels that
are both close in the spatial domain and similar in image intensity. Thus, the
spatial and the range domain information can be concatenated to generate a
joint spatial-range (or spatial-intensity) domain [26], namely the scalar value
I(x, y, z) in the range domain for a given voxel (x, y, z) is transformed to a
4D vector [x, y, z, I(x, y, z)] in the joint spatial-range domain. The mean shift
method is applied to the joint spatial-range vectors of all voxels within the ROI
to find their modes. The voxels sharing the same mode are partitioned into
the same sub-region; thus, the ROI is partitioned into different sub-regions.
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4.3 Evaluation of Segmentation Algorithm
Three factors, precision (reproducibility), accuracy (agreement with truth, va-
lidity), and efficiency (time taken), are usually considered in evaluating seg-
mentation methods [103]. In this dissertation, we emphasize on accuracy in
evaluating segmentation performance.
Note that the ultimate goal of segmentation is to to extract morphological
features that will be used as input features for the classifier or prediction
model; therefore more relevant in our study is to assess the impact of the
extracted morphological features from segmented lesions in subsequent classi-
fication stage.
4.3.1 Evaluation Metrics for Segmentation Accuracy
The quality of the lesion segmentation is traditionally evaluated using either
subjective or objective methods. The subjective evaluation by radiologists,
such as a five-level rating, is considered as the gold standard in clinical practice.
Without the known ground truth data obtained by non-imaging methods such
as histology, objective assessment of the accuracy of a segmentation algorithm
requires a surrogate for ground truth and an appropriate metric for comparing
the segmentation to the gold standard. Currently, the only accepted surrogate
for ground truth in the medical imaging community is manual segmentation
by human experts. Compared to the subjective evaluation, the objective met-
rics are easy to compute, but may not provide an overall assessment of the
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segmentation quality because each metric only captures a certain aspect of
the difference between the segmentation and the ground truth. Although the
study of methodology for assessing segmentation accuracy remains an active
area of research, there are several commonly used metrics, such as the volumet-
ric overlapping ratio, the Hausdorff distance, and the mean absolute surface
distance [41], that have proven useful in practice.
The overlapping ratio is a simple yet meaningful measurement; thus, we will
employ the overlapping ratio in our experiments to assess segmentation accu-
racy. There are several ways to define the overlapping ratio, such as the Dice
coefficient and the Jaccard coefficient. The Dice coefficient is defined as the
ratio of twice the size of the intersection of two sets divided by the sum of
two individual set sizes, as formulated in 4.7. A simple spatial overlap index
is the Dice similarity coefficient (DSC), first proposed by Dice (13). The Dice
similarity coefficient is a spatial overlap index and a reproducibility validation
metric. The Jaccard coefficient is defined as the size of the intersection of two







In (4.7) and (4.8), |.| denotes the number of pixels/voxels in a given set; A∩B
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denotes the intersection of set A and set B; while A ∪B denotes the union of
set A and set B. There is an explicit relationship between the Dice coefficient
and the Jaccard coefficient. Therefore there is no difference between Dice co-
efficient and Jaccard coefficient in characterizing the accuracy.
4.3.2 Evaluation of Segmentation Impact on Classification Perfor-
mance
The metrics are indicators of the segmentation performance. Our hypothesis
is that more accurate lesion segmentation will result in more accurate lesion
classification. More relevant about the segmentation performance in our study
is the subsequent classification performance resulting from the features derived
from the segmented lesion. A set of morphological features from the segmented
lesion can be extracted and their classification performance then will be eval-
uated. This evaluation method provides an indirect but more meaningful way
in assessing the segmentation methods.
In our study, we consider the manually segmented lesion as the “ground truth”
lesions, and the morphological features can be extracted from the segmented
lesions. Then a subset of features can be determined by the feature selection
method. The same subset of features will used in evaluating the classification
performance of other segmentation algorithms.
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4.4 Experimental Results
We carried out lesion segmentation on 40 lesions (20 malignant and 20 benign).
Some experimental results are shown in Fig. 4.1 to Fig. 4.4. The images shown
in Fig. 4.1 are the pre-contrast images and the 1st post-contrast images from
a patient diagnosed with a biopsy-proven invasive ductal carcinoma, and each
3D image is 208× 256× 256 in size. The ROI size of this case is 25× 37× 67,
as denoted by a red box in Fig. 4.1(b). The images shown in Fig. 4.2 are
enlarged sagittal views of the ROI and segmentation results by different algo-
rithms. The images shown in Fig. 4.3 are the pre-contrast images and the 1st
post-contrast images from a patient diagnosed with a biopsy-proven benign
fibroadenoma; in this case each 3D image is 168 × 256 × 256 in size and the
ROI size is 11× 18× 18.
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(a) Pre-contrast Image (b)First post-contrast Image
Figure 4.1: Axial, coronal, and sagittal views of raw 3D images from a patient
of 46 years old diagnosed with invasive ductal carcinoma.
4.4.1 Results on Segmentation Accuracy
To evaluate the segmentation algorithm performance, we manually segmented
out 40 lesions (20 malignant cases and 20 benign cases) as the “ground truth”
and compared the algorithmic outputs with the manual results. Three metrics;
sensitivity, specificity, and overlapping coefficient; were assessed, and the nu-
merical results are summarized in Table 4.1. Overall, the STAPLE algorithm
outperforms other algorithms in terms of all three metrics except that the
threshold-based algorithm performs best in term of sensitivity and in terms
of the Dice coefficient for malignant lesions. The performance of the Fuzzy
C-means algorithm is comparable to that of the mean-shift algorithm.
4.4.2 Segmentation Impact on Classification Performance
In our study, we evaluated lesion segmentation by its impact on the subsequent
classification performance. Similarly, the manually segmented lesions are used
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(a) 1st Post image (b) Manual map (c) Threshold-based seg
(d) Fuzzy C-means (e) Mean shift (f) STAPLE
Figure 4.2: Enlarged sagittal view (slice #43) of Fig.4.1(b) and the segmented
lesions.
(a) Pre-contrast Image (b)First post-contrast image
Figure 4.3: Axial, coronal, and sagittal views of raw 3D images from a patient
of 42 years old diagnosed with a benign fibroadenoma.
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(a) 1st Post image (b) Manual map (c) Threshold-based seg
(d) Fuzzy C-means (e) Mean shift (f) STAPLE








Threshold 0.976/0.970/0.974 0.981/0.994/0.986 0.716/0.905/0.783
Fuzzy C-means 0.868/0.862/0.866 0.991/0.990/0.991 0.757/0.798/0.772
Mean shift 0.831/0.944/0.871 0.992/0.990/0.991 0.739/0.831/0.772
STAPLE 0.966/0.967/0.967 0.992/0.993/0.992 0.848/0.899/0.866
Table 4.1: Segmentation accuracy for different algorithms compared against
manual “groundtruth”; B–benign lesions; M–malignant lesions; All–benign
and malignant lesions together.
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as “ground truth” in the experiments. The lesion features were automatically
extracted to quantify the characteristics of the lesion. A subset of features were
selected by the feature selection methods described in Section 6.2. The same
selected features of lesions, both manually segmented and maps segmented out
by algorithms, were evaluated using receiver operating characteristic (ROC)
analysis. The area under the ROC curve is used as the performance metric.
The classification results are summarized in Table 6.2. Based on the algorith-
mic segmentation outputs of 40 lesions (20 benign and 20 malignant each),
the STAPLE and the Mean Shift algorithms yield better classification results
than the Fuzzy C-means and the threshold-based methods.
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Chapter 5
Breast MR Image Registration
It usually takes around 20-40 minutes to scan a series of breast MR images.
During this relatively long acquisition process, respiratory and cardiac mo-
tions, as well as some degree of voluntary patient movement, are unavoidable.
As a result of such motion, the same coordinates in images at different times
in the series may correspond to different physical locations in the subject.
Thus, interpreting raw images can lead to errors in evaluating enhancement
and morphology of an abnormality. For this reason, one must compensate
for the motion across image volumes acquired sequentially in order to achieve
anatomical and functional correspondence. This process is referred to as reg-
istration.
In this chapter, we begin by introducing the general methodology of image reg-
istration, then followed by reviewing previous image registration methods for
breast MRI application. In our study, we conducted experiments by compar-
atively assessing the similarity metric in registering DCE breast MR images.
The performance of cross correlation(CC) coefficient, and mutual information
(MI) are studied in both rigid and non-rigid registration schemes. Numerical
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results and statistical properties are reported. The resulting image quality
after registration is discussed both qualitatively and quantitatively.
5.1 Overview of Image Registration
Registration is an essential tool in medical imaging. Because of the great
variety of registration techniques, here we only review image registration tech-
niques relevant to our application, breast MRI registration. We refer interested
readers to recent publications [48, 53, 87] for broader and more detailed surveys
on this topic. Suppose we have two images, a reference image, R, and a tem-
plate image, T , both of which are mappings from d-dimensional space to 1D,
i.e., R(x), T (x) : Ω := <d → < ( d = 3 in our application). The goal of image
registration is to establish correspondence between voxels in these two images
R and T . In general all image registration methods can be categorized as either
feature-based or intensity-based. The feature-based methods are based on fidu-
cial markers manually placed in the two images or salient features extracted
from the images, such as edges. Once the correspondence of feature points is
established, the two images can be aligned. In breast imaging, landmarks may
be attached to the skin or inserted inside the breast. Those attached to the
skin are non-invasive; however, the movement of skin may cause landmarks to
move several millimeters [48]. Landmarks placed inside the tissue can cause
discomfort or damage to the tissue [48]. Thus, fiducial markers are not used in
most current clinical breast MR image acquisitions. Another way is to identify
landmarks on images either manually by an operator or automatically by a
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Figure 5.1: The iterative process of intensity-based registration.
computer. Manually identifying corresponding landmarks on breast MR image
pairs is a challenging task even for experienced radiologists. Thus our study
focuses on intensity-based registration methods.
Intensity-based methods involve an iterative process, in which an initial esti-
mate of the transform is gradually refined (see Fig. 5.1):
(1) Generate a transformed template image based on the current transfor-
mation. Given a set of transformation parameters, each grid point in the
transformed template image may correspond to a non-grid point in the orig-
inal template image; thus, interpolation is necessary to evaluate the image
intensity on those non-grid points;
(2) Measure the similarity or closeness of the transformed template image to
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the reference image;
(3) If the closeness satisfies a pre-defined criterion, the iteration stops; other-
wise, the optimizer searches for a new set of transformation parameters and
steps 1-3 are repeated;
Each of these steps will be discussed in detail in the following paragraphs.
In general, transforms can be categorized as one of the following three types:
rigid transforms, affine transforms, or non-linear transforms. The rigid trans-
form only involves rotations and translations. In 3D, rigid transformation has
6 DoF (degree of freedom): three rotations (one about each axis) and three
translations. The rigid transform does not allow any structure within the im-
age to change size or shape. In comparison, the affine transformation model
permits scalings and skews in addition to rotations and translations; therefore,
it has 12 DoFs: 3 rotations, 3 translations, 3 scalings, and 3 skew parameters.
Rigid transformation is a special case of affine transformation. Although affine
transform allows both size and shape changes, the changes must be the same
across the entire image. Mathematically, the affine transform can be described
in a linear form. Transforms that are not affine are referred to as non-linear
transforms.
A variety of non-linear transforms have been proposed based on different math-
ematical or physical models. The elastic model [5, 39] and the fluid model [24]
are the most advanced registration methods available. The elasticity model
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assumes linear elasticity of the soft tissue, allowing the relative positions of
physical tissue points to be altered. This relative position change of physi-
cal points is referred as deformation. An elastic model deforms the image to
reach the desired deformation by balancing between internal strain and ex-
ternal force. The internal strain is intrinsic to the elastic model while the
external force is the similarity metric to be discussed later in this section.
Due to the intrinsic internal force, the elastic model constrains the deforma-
tion to be globally smooth. Thus, the elastic model can not accommodate
large, complex deformations. To overcome this limitation, the fluid model
[24] has been proposed to control the deformation in which the internal force
term disappears gradually so that the desired deformation can be reached.
The original implementation by Christensen [24] is computationally intensive,
but fast implementation techniques have been proposed by other researchers
[13, 110]. However, fluid registration introduces noticeable blurring artifact to
the transformed image.
After the template image T is transformed according to the chosen transform,
it needs to be re-sampled to generate an intermediate image, then this discrete
image is compared against the reference image R. The re-sampling process
necessarily involves interpolation. The ideal interpolation kernel is the sinc
function. However, the sinc interpolation kernel is impractical to implement
due to its infinite support. Several other interpolation kernels have been in-
vestigated, such as various order B-spline interpolation kernels. Linear (order
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1 B-spline kernel) interpolation causes errors though it is cheap to compute.
Netsch et al. [74] demonstrated that cubic and quintic B-spline interpolation
are favorable in terms of computational cost and consistency of registration
results. Wu et al. [112] also demonstrated that B-spline kernels are superior
to other types of interpolation kernels in terms of interpolation accuracy and
computational cost.
The three most common distance metrics used to measure the similarity or
closeness of the reference image to the transformed template image are: (1) L2
norm, namely, the sum of squared difference (SSD), (2) correlation coefficient
(CC), and (3) mutual information (MI). The mathematical definitions of these
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PIAIB(a, b)logPIAIB(a, b) ∀ IA(x) = a & IB(y) = b(5.6)
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IA and IB are two images to be compared, and N is the total number of pix-
els/voxels in the overlapping region of the two images. IA and IB are the mean
image intensity values of images IA and IB, respectively. H(IA) is the entropy
of image IA, and H(IB) is the entropy of image IB. Likewise, the term H(IA, IB)
is the joint entropy of two images IA and IB, which reflects how much the joint
histogram of two images disperses. From 5.3, we can see that maximization of
MI is equivalent to minimization of joint entropy H(IA, IB). The more similar
the two histograms PIA and PIB are, the less dispersion the joint histogram
PIAIB shows, and the lower the value of the joint entropy, H(IA, IB). More
details about MI and its application in image registration are available in a
recent review article [87].
Appropriate selection of a distance/similarity metric is critical to the perfor-
mance of an image registration method. In terms of computational cost, SSD
is the cheapest metric while correlation and MI are more computationally in-
tensive. In term of applicability, SSD can be used when there is no or little
intensity variation for the same tissue across an image pair; therefore, SSD
is often used for intra-modality registration. If the image intensities for the
same tissue in two images are significantly different or for inter-modality reg-
istration, SSD is a poor metric choice while CC or MI can be used instead.
From the definitions of CC and MI, it is clear that CC is optimal when there
is a linear relation between the intensities across an image pair, and mutual
information is maximized when the histograms of the two images are very sim-
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ilar to each other. Therefore, both CC and MI can be used for inter-modality
registration.
5.2 Previous Work on Breast MRI Registration
To our knowledge, no previous breast MRI registration algorithms involve
landmarks. Thus, all previous work on this subject falls into the category of
intensity-based image registration. Although intensity-based image registration
is a traditional, well-explored topic in image analysis and computer vision, ex-
isting techniques cannot be simplistically applied to breast MRI. For example,
some registration algorithms assume that the image content does not vary
much across the images to be registered, but this is not the case for DCE
breast MRI. In fact, the key feature of DCE breast MRI is the enhancement of
abnormal tissues after the administration of the contrast agent. Since breast
tissues are soft tissues, the motion of different tissues may not be the same, so
a non-linear transformation or a non-rigid motion model is preferred, as also
discussed by Rueckert et al. [91]. Additionally, breast MRI is a 3D exam with
high spatial resolution, so true 3D registration techniques would be preferred.
Rueckert et al. [91] introduce a non-rigid 3D registration method for breast
MRI based on free-form deformations. The local motion model is a free-form
deformation model based on B-splines to analyze the motion of the breast,
and the choice of cubic B-splines produces a smoothly varying displacement
field. In this scheme, a normalized mutual information criterion is chosen to
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maximize the similarity between the pre-contrast image and post-contrast im-
age. It should be recognized that the image intensities of certain regions, e.g.,
tumors and blood vessels, vary over time due to the wash-in and wash-out of
the contrast agent. This intensity change inevitably leads to differences be-
tween the histograms of any volume pair in a dynamic series, even if the two
volumes are perfectly aligned. Moreover, the dispersion of the joint histogram
depends largely on the size of the enhancement region. If the enhancement
region is small, the overall joint histogram has little dispersion. In contrast,
if the enhancement region is substantial compared to the entire image, one
should expect large dispersion in the joint histogram and thus the joint en-
tropy will not be small.
To accommodate the fact that the image intensity of the tumor region in breast
MRI changes with time, the standardized compartmental model (see Fig. 2.4)
is widely used to derive physiological parameters of tissue underlying DCE
MRI. This modelling process involves the following steps:
(1) Convert the image intensity to T1 values;
(2) Convert the dynamic T1 values to contrast agent concentration;
(3) Estimate the contrast agent concentration in plasma, this is the so called
arterial input function (AIF) estimation;
(4) Use the standardized two-compartment model for parameter estimation
based on the diffusion of the contrast agent between the plasma and the tu-
mor cells.
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In step (1), there may exist an analytical relationship between the T1 value
and image intensity depending on the hardware and the MRI sequence choice.
Step (2) is to measure the contrast agent concentration from the dynamic T1
values (MRI signals). Since the addition of the contrast agent only alters the
MRI signals indirectly by changing the relaxitivity of the water surrounding
the contrast agent, the exact effect is not fully understood. Previous studies
assume that the T1 value changes linearly with the change in the concentration
of the contrast agent. However, recent research indicates that this relationship
is non-linear and dependent on the intrinsic tissue type. Regarding step (3),
several AIF models have been proposed, but experiments indicate that these
models do not fit all individual studies well. Another alternative is to calculate
the AIF directly from the image intensity, which involves steps (1) and (2).
Very often, the assumptions made may not be valid for every tumor type, as
discussed by Collins and Padhani [25]. Furthermore, it is difficult to validate
the accuracy of the model-based parameters as there is no existing clinical
standard.
Hayton et al. [51] use a modified Horn and Schunck optical flow model to
minimize the fitting error of a two-compartment model. The consistency of the
pharmacokinetic model fitting is used as the similarity criterion in registration.
Buonaccrosi et al. [14] proposed to register the raw image and a synthetic
image of the same time point, with the synthetic images generated by a two-
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compartment model. As discussed above, model failures can occur and would
decrease the overall registration accuracy.
5.3 Comparative Assesment of Similarity Metric
5.3.1 Study Goal and Experiment Designs
As discussed in Section 5.1, it is a difficult choice in deciding the best registra-
tion scheme to optimize the registration performance. Appropriate selection
of a distance or similarity metric is critical to the performance of an image
registration method. Three commonly used similarity metrics are introduced
in Section 5.1. However, a successful breast MRI registration technique must
take into consideration that the image intensity changes over time. This fea-
ture of breast MRI means that SSD is not a viable similarity metric even
though the images to be registered are from a single modality. CC and MI
are both very popular similarity metrics and could be used in our application.
In our study, we conduct comparative assessment of the similarity metric in
registering DCE breast MRI data.
The overall motion of the breast consists of two forms of motion: global mo-
tion, such as that caused by body movements; and the local motion, such as
that caused by breathing and the heart beating. Global motion can be char-
acterized using a rigid motion model; while local motion is more appropriately
modelled by a non-rigid model.
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In our study, we design experiments to assess the performance of similarity
metrics in both rigid and non-rigid registration. Since the MR images are
always compromised by Rician noise, it is worthy of evaluating the robustness
of the similarity metric in the presence of noise. The complicating factors of
Rician noise, and non-rigid motion make the problem difficult to analyze in
theory and suggest that a numerical study is more appropriate.
5.3.2 Assessment on Global Motion Correction
A rigid transform can include one or more transformations, such as rotation,
translation, and scaling. In our application, the object sizes on image do not
vary due to the hardware setup. Therefore we evaluate the performance of
similarity metric only on two transformations: rotation and shift.
First we computed the similarity measures as a function of the rotation parameter–
rotation angle θ. In the experiments, we have a pair of synthetic images(see
Fig. 5.2), in which different sizes of objects are placed and the image intensi-
ties of the objects change across image pairs. Both CC and MI are maximized
at a true value θ = 0 if the images are free of noise. To test the robustness of
the similarity metrics, we added noise on the template image ( see Fig. 5.2 for
two noisy images). Note that the noise is in Rician distribution (noise of both
real and imaginary channels are in Gaussian distribution ). The performance
of similarity metrics in the presence of noise is plotted in Fig. 5.3. We can see
that MI outperforms CC with noise at all noise levels.
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(a) Reference Image (b)Template Image
(c) Noisy template1 (12.73%) (d)Noisy template2 (28.28%)
(e) Registered (c) using CC (f) Registered (c) using MI
(g) Registered (d) using CC (h)Registered (d) using MI
Figure 5.2: A pair of images simulating different size objects, and the template
image is added with low and middle level Rician noise.
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(a) CC vs. rotation angle (b) MI vs. rotation angle
Figure 5.3: Both CC and MI are maximized at a true value θ = 0 if images are
free of noise. The noise levels for noise 1, 2, 3, 4 are 6.02%, 11.3%, 18.0%, 22.8%
respectively. With noise, CC coefficients are maximized at 0.1, 0.2, 0.3, 0.3
degrees respectively; while MI coefficients are maximized at 0, 0.1, -0.1, -0.1
degrees respectively.
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Figure 5.4: Monte Carlo simulation for rotation angle estimate error using
similarity metrics MI and CC versus Rician noises
.
72
The results in Fig. 5.3 were for a single noise realization, so they do not fully
characterize the statistics of rotation parameter estimate. We then performed
200 noise realizations at each of these noise levels and computed the rotation
parameter estimates θ̂. The mean value and standard deviation of the estimate
error are plotted in Fig. 5.4. The MI can still detect the true rotation angle
at low level noise, while CC is more vulnerable to noise. The experimental
results suggest that MI is more robust than CC for rotation transform.
More relevant here is not the absolute accuracy of the rotation angle, but the
resulting image quality after registration. Of particular note is the algorithmic
capability in preserving the small sized lesion. In this experiment, different
sized objects simulating lesions were placed in the images. Therefore we can
assess the registration quality by observing the smallest-size object preserved
in the image after registration. See (e,f,g,h) of Fig. 5.2 for four examples.
Similar to the experiments on rotation transform, we comparatively assess the
CC and MI regarding the translate transform. The results suggest that MI is
more robust than CC.
5.3.3 Assessment on Local Motion Correction
The local deformation of the breast is more appropriately modelled by a non-
rigid motion. Several non-rigid models, such as the elastic model and the fluid
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Figure 5.5: Monte Carlo simulation for the translate estimate error using
similarity metrics MI and CC versus Rician noise levels
.
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model etc., can be used in modelling the local motion. However, the effect of
motion model is beyond the scope of this dissertation. We focus on assessing
the performance of similarity metrics, CC and MI. In our experiments, we
employ the elasticity model in [5]. The problem is to find a spatial displacement
field u that satisfies the following partial differential equation
µ∇2u + (λ + µ)∇(∇ · u) = F(u) (5.7)
where µ and λ are two constants defining the elastic properties of the breast
tissue. F(u) is the variational gradient of the chosen similarity coefficient.
In the synthetic image test cases (See Fig. 5.6), 2 light regions simulating the
breasts are subject to shape changes only, while an embedded region in each
breast simulating the lesion that takes up contrast is subject to changes in both
shape and intensity. The elastic model of 5.7 is applied for motion correction.
In term of resulting image quality, more relevant is the accuracy in preserving
the objects of interest than the absolute accuracy of the displacement field u.
In our study, the object of interest refers to the lesion in the breast. We can
compare the level of overlap between the lesion after registration and that in
the ground truth image. The kappa metric (κ), also called Dice coefficient,
is used for this purpose. The results in Fig. 5.6 are without noise. To test
the robustness of the similarity metric in the non-rigid registration, we then
performed 200 noise realizations at different noise levels and computed the
resulting overlapping metric κ (see Figures 5.7 and 5.8). The numerical results
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(a) Reference Image (b)ideal Template Image
(d) Deformed Template1 (e) κl/κr = 0.8571/0.9253 (f) κl/κr = 0.850/0.9353
(g) Deformed Template2 (h) κl/κr = 0.7576/0.8943 (i) κl/κr = 0.7483/0.8989
Figure 5.6: Image (a) is the reference image, while image (b) is the ground
truth template image without motion. In rows 2 and 3, the images of the
second column are motion-corrected images of those in the first column em-
ploying the CC as the similarity metric; and the images of the third column
are motion-corrected images of those in the first column employing the MI
as the similarity metric. κl and κr denote the overlapping coefficient of the
registered lesion map and its corresponding ground truth lesion map in the
left breast and in the right breast respectively.
suggest that the CC and the MI perform similarly for image with low or middle
level noise, and the MI slightly outperforms the CC in the presence of high
level noise.
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Figure 5.7: Monte Carlo simulation for the overlapping coefficient of the left
lesion versus Rician noise
.
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Figure 5.8: Monte Carlo simulation for the overlapping coefficient of the right
lesion versus Rician noise
.
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5.4 Summary and Registering Clinical DCE Breast MRI
data
In this chapter, we comparatively study the performance of the cross corre-
lation (CC) coefficient, and the mutual information (MI) in both rigid and
non-rigid registration schemes. We numerically study the impact of similarity
coefficient on image quality after registration. The numerical simulation re-
sults demonstrated that the performance of the CC is comparable to that of
the MI in the presence of low-level noise, and MI outperforms CC for images
with middle or high level noise.
In real clinical breast MRI acquisition, the images are susceptible to noise
corruption. In our subsequent experiments of registering clinical DCE breast
MRI data, we choose MI as the similarity metric and demonstrate its perfor-
mance with an example shown in Fig. 5.9. The cross-hairs in images indicate
the same coordinates in the images. We can observe that there is obvious
motion between the 3rd post-contrast image and the 4th post-contrast image
compared with the 1st post contrast image (baseline image). Due to motion
effect, the kinetic curve directly extracted from raw images doesn’t charac-
terize the kinetic features of this benign cyst. After motion correction, the
extracted kinetic curve fits more to a typical benign kinetic curve. The kinetic
curves before and after registration are shown in Fig. 5.10.
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(a) The 1st post image (b)The 3rd post image (c) The 4th post image
(d) The 1st post image (e)Registered 3rd post image (f) Registered 4th post image
Figure 5.9: The top three images (a)-(c) (sagittal view) are raw images ac-
quired from a 60-year-old woman with a history of atypical ductal hyperplasia.
The region centered at the cross-hair is a benign cyst at 3 o’clock region of left
breast. The 1st post-contrast image is used as baseline image in registration
and motion-corrected images are shown in (e) and (f).
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Figure 5.10: Five-point kinetic curves of images in Fig. 5.9. Of each curve, the
1st point represents pre-contrast signal, while the other four points represent




The goal of breast MRI is to non-invasively assess abnormalities. For example,
if one can be sufficiently certain that a lesion is benign, then the woman can be
spared a biopsy. Unfortunately, one of the main criticisms of breast MRI has
been its low specificity [89]. Moreover, the specificity of breast MR appears to
depend heavily on the radiologist’s level of experience [61]. Currently, there
is no standardized algorithm for lesion classification. Although it is widely
accepted that both morphological and kinetic features on breast MRI should
be evaluated in making diagnostic and treatment decisions [60, 79, 95], man-
ual rating of these features is subject to inter- and intra-observer variability
[57, 99, 108]. Ideally, the extraction of lesion descriptions could be automated
using image processing methods, and then used as inputs for a classifier that
outputs a decision on whether the lesion is benign or not.
This chapter presents a classification system based upon quantitative morpho-
logical and kinetic features in improving the specificity of breast MRI. Mor-
phological and kinetic features of the lesion are extracted automatically, and
then the feature selection step is utilized to select the most relevant features
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to optimize the classifier performance. In our study, the area under receiver
operating characteristic curve (AUC) is used as the performance metric of the
classifier. Results of each stage of the classification system are reported.
6.1 Overview of Previous Algorithms for Lesion Classi-
fication
The American College of Radiology has defined a lexicon (Breast Imaging,
Reporting, and Data System - BI-RADS [79]) that provides a set of diagnos-
tic features that could be used for developing an automatic classifier. How-
ever, current radiological practice involves manual rating of these features,
which is subject to inter- and intra-observer variability [57, 99, 108]. Classi-
fication based on BI-RADS descriptors [6, 36, 102] and automatic extraction
of BI-RADS descriptors [82, 92] have been investigated for other modalities.
Some efforts have already been made to automatically predict lesion pathol-
ogy based on morphological features, kinetic enhancement features, or both
[22, 42, 44, 67, 94, 100, 104]. Some such studies [22, 44, 94] have demonstrated
that a combination of morphological features and kinetic enhancement fea-
tures provides better classification than either feature set alone. A previous
study also suggests that better classification is obtained when 3D features of
the lesion are used as compared to when 2D features are measured slice by slice
[44]. As is the case for many classification tasks, previous studies comparing
univariate and multivariate regression models for predicting lesion pathology
from breast MRI findings have demonstrated that features with marginal clas-
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sification performance individually may still yield high predictive values in
combination [94]. Several investigations of automatic classification of lesions
on DCE breast MRI as benign or malignant are summarized in Table 6.1.
6.2 Our Framework for Lesion Classification
Our long term goal is to automate the workflow of interpreting breast MRI
exams and to minimize the interpretation error and observer variability. The
goal of the proposed classification study is to develop a model based on mor-
phological and kinetic features that will be extracted automatically and char-
acterized quantitatively using image processing methods. We hypothesize that
our proposed segmentation and registration algorithms will yield more accu-
rate delineations of these features and so lead to a more accurate classification
performance. There are four major design considerations in developing a clas-
sification model: (1) feature extraction, (2) feature selection, (3) classifier
training, and (4) evaluation metric. We consider each of these issues in turn
in the following paragraphs.
6.2.1 Feature extraction
In our study, both the morphological and the kinetic features of the lesion
are to be extracted automatically and characterized quantitatively using im-
age processing methods. It should be noted that all kinetic features will be













Arbach [4] SA A N/A Morp ANN 35 Az=0.913







Gibbs [42] M A Backward Kine LR 43 (no cross-
validation)
Az=0.92













Lucht [67] M A N/A Kine ANN 258/111 Sens.=84%,
Spec.=81%
Nunes [75] M M N/A Morp 98/94 Sens.=96%,
Spec.=79%
Schnall [94] M M Regression Morph,
kin, clin
Multivariate995 Az=0.88
Szabo [100] M A ARD Morph,
kine
ANN 59/46 Az=0.77











Table 6.1: Summary of studies on developing classifiers to predict lesion
pathology on breast MRI. A - automated; SA - semi-automated; M - man-
ual; ANN - artificial neural network; LDA - linear discriminant analysis; LR
- logistic regression; CART - classification and regression tree; ARD - auto-
matic relevance determination; LOOCV-leave-one-out cross validation. Az -
Area under the ROC.
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(a) Mean Curve of Benign Cases (b)Mean Curve of Malignant Cases
Figure 6.1: Mean kinetic curves of benign cases and malignant cases. The
kinetic curves are normalized with respect to the pre-contrast signal of each
case and then averaged.
6.2.1.1 Kinetic Features Extraction
In our experiments, the baseline (pre-contrast signal) is normalized as 1; and
the post-contrast signals are normalized with respect to their baseline signal.
The typical normalized kinetic curves are plotted in Fig. 6.1. Since the base-
line signals are always 1 for all lesions (benign and malignant), they do not
provide any discriminatory power. From Fig. 6.1, we can observe that the
1st , 2nd and 3rd post-contrast signals together provide rich discriminatory
information, and the 4th post-contrast signal may provide additional informa-
tion. This observation is coincident with conclusions of previous studies that
the wash-in rate and the washout-rate are important features to characterize
lesion [62].
To extract more salient information from post-contrast signals, a linear fea-
ture extraction was obtained by using a linear transform-principle component
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(a) Mean PCA coefficients of Benign Cases (b)Mean PCA coefficients of Malignant Cases
Figure 6.2: Mean PCA coefficients of benign cases and malignant cases, note
that only normalized post-contrast signals are projected into each principal
axis and then averaged.
analysis (PCA). PCA coefficients are data formed by projecting the normalized
post-contrast signals into the space of the principal components. Therefore we
could use the PCA coefficients as a new set of kinetic features. See Fig. 6.2
for mean PCA coefficients of malignant and benign cases respectively. We can
observe that the first two major components provide powerful discriminatory
information, and the last two components are of little use in discriminating
the benign case from the malignant one.
6.2.1.2 Morphological Features Extraction
After the lesion is segmented out from the 3D post-contrast image, some ge-
ometric features of the lesion can be extracted, such as its spiculation, aspect-
ratio and compactness.
Spiculation is computed as the standard deviation of the radial length of all
points on the segmented lesion surface. The radial length is defined as the
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Figure 6.3: Distribution of morphological features sampled from 40 cases (20
benign cases and 20 malignant cases). The blue circles denote benign cases
while the red diamonds denote malignant lesions.
distance from a boundary point to the geometric center of the lesion. The
compactness of a mass lesion can be defined as the ratio of its surface area to
its volume. Ideally, the compactness of a round or an oval mass is small, while
that of a spiculated mass is large. Thus, the compactness of a mass is another
quantitative measure of the likelihood of malignancy. The aspect-ratio can be
defined as ratio of the maximal diameter and to the minimal diameter of the
bounding box, and this ratio is a quantitative measure of the likelihood that
the mass is malignant [20]. Ideally, the aspect-ratio of round masses is close
to 1, that of oval masses is larger than 1 and that of lobular masses is even
larger.
The aforementioned morphological features have been efficiently utilized in
previous work to classify breast lesions [4, 55]. In Fig. 6.3, we plot a distribu-
tion map of spiculation and compactness.
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The morphological features, such as spiculation and compactness, can be ex-
tracted from both the 3D lesion and from the 2D representative slice. In our
experiments, we extracted the 3D and 2D morphological features and used the
feature selection step to determine the most relevant features for classifiers.
6.2.2 SVM-based Classifier
A variety of statistical machine learning algorithms could be used to classify
a suspicious lesion as likely benign or likely malignant based on the extracted
features. The classifiers, such as linear discriminant analysis (LDA) [32] and
support vector machine (SVM) [15, 29] could be utilized for our classification
purpose. SVMs are a set of machine learning methods used for classification
and have come into widespread use for many biomedical classification tasks.
We discuss the principles of SVM in the following paragraphs.
Suppose we have a set of data points D = {(xi, yi)|xi ∈ <p, yi ∈ {−1, 1}}ni=1.
We can construct a separating hyperplane that divides those points having
yi = 1 from those having yi = −1, such a hyperplane can be denoted as
x : f(x) = xT β + β0 = 0 (6.1)
where β is an unit normal vector perpendicular to the hyperplane, see Fig. 6.4.
Our goal is to maximize the margin (distance) between data of two classes,
and this problem can be formulated as
max C s.t. yi(x
T
i β + β0) ≥ C, i = 1, . . . , n (6.2)
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The optimal hyperplane can be determined by using only those data points on
the margin, so called support vectors [29]. The optimization problem 6.2 can
be reformulated as
min‖β‖ s.t. yi(xTi β + β0) ≥ C, i = 1, . . . , n (6.3)
Very often, the data cannot be cleanly separated by a hyperplane, thus there
are some mislabeled data. The method by Cortes and Vladimir [29] introduced
slack variables, ξi, to measure the amount of misclassification of xi. Therefore,










where K is a constant. By bounding the total misclassification amount
∑
ξi,
we bound the total number of mislabeled data.
In order to extend the SVM methodology to handle data that is not linearly
separable, a non-linear kernel function was suggested to map the data into a
higher dimensional space that is linearly separable. Commonly used non-linear
kernel functions include the radial basis function (RBF) and the Sigmoidal
kernel. The SVM will be applied to solve our classification problem in this
dissertation project. Since it cannot be known a prior if benign and malignant
lesions are linearly separable in the proposed feature space, we need to compare
the performance of the linear kernel to that of the non-linear kernel when
applying SVM. The libsvm software package [19] was used to implement the
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(a) Separable case (b) Non-separable case
Figure 6.4: Support vector classifiers. The red and green points represent
data belonging to different classes. In (a), the maximal margin width is 2C.
In (b), the points with ξ∗i represents those mislabeled data on the wrong side
of margin by an amount of Cξi; and points corrected labelled have ξ
∗
i = 0.
Picture courtesy of [37].
SVM classifier and the RBF kernel was selected as the non-linear kernel in our
experiments.
6.2.3 Feature Selection and Ranking
Some features may prove to be irrelevant or redundant, which can degrade the
classifier performance [47]. Feature selection refers to the process of identi-
fying a subset of features that is most valuable for classification according to
quantitative criterion [47].
In order to accomplish optimal classification performance, each variable or fea-
ture needs to be evaluated on its effect on the classification to identify relevant
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features. Of the existing feature ranking methods, some are related to certain
classification methods while some are independent of classifiers. For example,
the Fisher-score, a correlation coefficient between the feature and the label,
is a simple and efficient criterion in ranking features. In addition to Fisher-
score, we also evaluated subset relevance based on the SVM criteria, such as
the weight vector norm and upperbounds of the leave-one-out error, with re-
spect to a variable [88]. The latter strategy has the advantage of yielding high
classification performance, as confirmed by the experimental results. Our fea-
ture ranking procedure is implemented using the software package downloaded
from webpage of the first author of [88].
6.2.4 Classifier Training and Evaluation Metric
The ideal classifier training process requires three independent sets: a training
set, a validation set, and a testing set. However, when the available data are
limited, as is the case in this pilot study, a cross-validation strategy is used. In
K-fold cross validation, the data set is randomly partitioned into K disjointed
sets of equal size. The classifier is trained K times with a different set held
out as the validation set each time. The special case of K-fold cross-validation
in which K is equal to the number of samples is referred as leave-one-out
cross-validation or round-robin training. Leave-one-out cross-validation has
been widely adopted for the analysis of biomedical classification tasks based
on small data sets and was also employed in this dissertation project.
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As it is the standard practice in evaluating clinical decision aids for binary
classification tasks, receiver operating characteristic (ROC) analysis will be
used for evaluating the classifier developed in our study. An ROC curve shows
the tradeoffs in sensitivity and specificity that can be achieved by varying the
threshold on the decision variable [76]. The area under the ROC curve (AUC)
is a common summary measure of the performance of a classifier, and stan-
dard statistical methods exist for comparing the AUCs of different models or
feature sets.
6.3 Classification Experimental Results
In this section, we describe our experiments in evaluating the extracted mor-
phological and kinetic features. We first performed classifications on kinetic
and morphological features independently, and selected the features to opti-
mize the classification performance respectively. The features were compared
using the feature selection method and the leave-one-out classification proce-
dure explained in Section 6.2. We then combined the selected features, and
repeated the feature selection step on the combined feature set in order to
select features that yielded the best overall classification performance. The
experimental results are detailed in following paragraphs.
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6.3.1 Classification Experiment on Kinetic Features
We can do lesion classification on the normalized post-contrast signals or ex-
tracted PCA coefficients. To compare these two feature sets, we applied the
same feature selection and classification procedure on each of them separately.
We first used the normalized post-contrast signals for classification. There
are signals at four post-contrast time points. We ranked them according to
the method described in Section 6.2.3. See Fig.6.5 for the ROC performance
vs. the number of features used. The ROC curve for best AUC values in
Fig.6.5(a) are plotted in Fig.6.5(b). For linear model, all post-contrast signals
are needed to maximize the classification performance. For nonlinear model,
the first post-contrast value and the late post-contrast are sufficient to produce
the best result. By using the normalized post-contrast signals as features, the
nonlinear SVM model resulted in a better performance (Az = 0.813) than the
linear SVM model (Az = 0.766).
We then use the PCA coefficients as classifier inputs. The PCA coefficients
are data formed by projecting the normalized post-contrast signals into the
space of the principal components. We can use the PCA coefficients as a new
set of kinetic features. See Fig.6.6 for the ROC performance versus the num-
ber of features used. The ROC curve for best AUC values in Fig. 6.6(a) are
plotted in Fig. 6.6(b). For the linear model, only two major components are
needed to maximize the classification performance. For the nonlinear model,
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(a) AUC vs. ranked post-contrast signals (b)ROC curves
Figure 6.5: Classification results using normalized post-contrast signals as
kinetic features.
all PCA components are needed to produce the best result. By using the
PCA coefficients as classifier inputs, the linear SVM model resulted in a bet-
ter performance of (Az = 0.822) than the non-linear SVM model (Az = 0.809).
6.3.2 Classification Experiment on Morphological Features
Two steps were performed to evaluate the segmentation algorithms and their
derived features. First, we selected the most relevant features that maximize
the classification accuracy. The experiments were tested on a set of features
extracted from manually segmented lesions. We tested the morphological fea-
tures using both the linear kernel SVM and the non-linear (RBF) kernel SVM
methods. The features were ranked by the method described in [88], and
the results are presented in Fig. 6.7. We can see that the non-linear kernel
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(a) AUC vs. ranked PCA coefficients (b)ROC curves
Figure 6.6: Classification results using PCA coefficients as kinetic features.
method outperforms the linear kernel method for classification when using only
the morphological features of lesion, and the compactness index of the repre-
sentative 2D slice and 3D spiculation index are the two most relevant features
that optimize the classifier performance in using non-linear kernel SVM.
The second step was to evaluate the impact of different segmentation algo-
rithms on lesion classification. According to classification results based on
manually segmented lesions, the two most relevant morphological features are
the compactness index of representative 2D slice and 3D spiculation index.
We then extracted these two morphological features from lesions segmented
by different algorithms, such as threshold-based method, mean-shift method,
Fuzzy c-means method, and the STAPLE method. SVM methods were em-
ployed to compute classify lesions based on their morphological features. The
classification results are summarized in Table 6.2. Based on the algorithmic
segmentation outputs of 40 lesions (20 benign and 20 malignant), the STAPLE
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Figure 6.7: AUC vs. number of morphological features using different SVM
kernels.
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(a) Threshold and mean shift methods (b) Fuzzy C-means and STAPLE methods
Figure 6.8: Classification results using morphological features from lesions
segmented out by different algorithms.
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Segmentation method Accuracy AUC
Volume Threshold 15/20 0.82
Fuzzy C-means 13/20 0.78
Mean Shift 17/20 0.94
Staple 17/20 0.94
Table 6.2: Best classification performance metrics of lesion segmented out by
different algorithms
and mean shift algorithms yielded better classification results than the Fuzzy
C-means and the threshold-based methods.
6.3.3 Classification Experiment on Combined Features
According to results of previous experiments, we know that the most relevant
morphological features are the compactness index of representative 2D slice
and 3D spiculation index, and the most relevant kinetic features are the first
two major PCA coefficients of normalized post-contrast signals. In this exper-
iment, we performed classification using a combination of the most relevant
morphological features and most relevant kinetic features, and this new set of
features were again applied using feature selection procedure and 5-fold cross-
validation procedure described in previous section. The best classification
results are summarized in Table 6.3.
From Table 6.3, we can observe that combining morphological and kinetic
features improves the AUC value or the best classification rate as compared
to using the morphological features or the kinetic features alone. The ex-
perimental results are consistent with findings of previous studies that both
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Feature AUC Selected features
Morphological 0.94 spiculation(3D) and compactness(2D)
Kinetic 0.822 First two major PCA coefficients
Morphological + Kinetic 0.952 spiculation(3D), compactness(2D), and
first two PCA coefficients
Table 6.3: Best classification performance and their corresponding sets of fea-
tures used in lesion classification
morphological and kinetic features are important in distinguishing between
malignant and benign breast lesions.
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Chapter 7
Summary and Future Directions
7.1 Summary of this dissertation
This dissertation is a pilot study of developing a computational image analysis
prototype system for an increasingly used breast imaging modality–dynamic
contrast-enhanced breast MRI. We developed image analysis methods that
ultimately may improve the performance of each of the major algorithm com-
ponents that would be needed in a breast MRI CADx system.
In realizing our prototype system, we utilize both morphological and kinetic
features of the lesion on breast MR images. To extract morphological fea-
tures, the lesion needs to segmented out from its surrounding tissues; we uti-
lized STAPLE algorithm to combine segmentation maps generated by several
algorithms, and further evaluate performance of segmentation algorithms by
their impact on subsequent classification system. To compensate for the mo-
tion across image volumes acquired sequentially, we comparatively assessed
the similarity metrics, cross correlation coefficient and mutual information,
in registering DCE breast MR images. Based upon quantitative morpholog-
ical and kinetic features, we implemented a classification system in order to
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improve the specificity of breast MRI. The morphological and the kinetic fea-
tures of the lesion were extracted automatically, and then a feature selection
step was utilized to select the most relevant features to maximize the classifier
performance. In our study, the area under ROC curve (AUC) is used as the
performance metric of the classifier, and our results are competitive with those
of previous studies.
As breast MR imaging hardware equipment and acquisition techniques are
evolving, for example, high field scanners, such as 3T, have been shown to
produce more clearer delineation of tumor; and fast imaging methods are still
being developed to accelerate image acquisition; however, we expect that the
image analysis methods developed in this project can be similarly applied on
images acquired by future techniques or scanners.
7.2 Future Directions
In the future, the breast MRI will be increasingly and routinely used, as a
diagnostic, biopsy, staging, and treatment monitoring technique in breast can-
cer patient care. Research on breast image analysis is essential to fully exploit
and efficiently utilize the imaging information that has been acquired. Here we
discuss two aspects that are critical in developing future breast image analysis
systems.
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7.2.1 Multimodality Imaging Information Integration
In clinical practice, very often the information from multiple modalities in-
stead of just one modality is used in making a diagnosis. The information from
different modality can complement to each other, for example, mammography-
occulted cancers may be detected by breast MRI or ultrasound. Also the infor-
mation from different modality can provide correlative findings, for example,
breast MRI can be used to further evaluate a finding on mammography or
breast ultrasound. Therefore it is necessary to develop a breast image analysis
system that is capable of integrating multimodality information.
A challenge in imaging information integration involves image fusion/registration
that would establish the correspondence of the same physical object on images
from different modalities. This involves registration from 2D images (mam-
mogram or ultrasound image) to 3D images (tomosynthesis, or breast CT, or
breast MRI), from 2D images (mammogram) to 2D images (breast ultrasound),
and from 3D images (breast MRI) to 3D images (breast CT or tomosynthesis).
7.2.2 Breast Image Database
One should recognize that the imaging scanners from different manufacturers
and the image acquisition protocols at different sites will be variable. The
comparison and evaluation of image analysis techniques against each other
requires common data sets for evaluation, which is a starting point for devel-
oping clinically-applicable image analysis methods. Additionally, researchers
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working on breast image analysis usually have access to a small number of
single modality or multi-modality breast images on which to develop and test
their work. For the purpose of promoting breast image analysis, there is a
critical need to construct a database of breast images as research resources.
The proposed database should contain several image data sets. For example,
X-ray mammography data, ultrasound images, and breast MR images should
be included. All abnormalities on images should be confirmed by pathology
reviews. There also should be a consensus criteria for preparation and sub-
mission of cases that are representative of clinical practice to include typical
types of tumors. Such a database can be used not only as a testbed for image
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